Comparison between DNV Food Products IPO and Injecto Polymers IPO.
DNV Food Products IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Injecto Polymers IPO is a SME Bookbuilding proposed to list at BSE SME.
The total issue size of DNV Food Products IPO is up to ₹0.00 Cr whereas the issue size of the Injecto Polymers IPO is up to ₹0.00 Cr. The final issue price of DNV Food Products IPO is and of Injecto Polymers IPO is .
| DNV Food Products IPO | Injecto Polymers IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 51,30,000 shares | 56,13,500 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 51,30,000 shares | 56,13,500 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
DNV Food Products IPO opens on , while Injecto Polymers IPO opens on . The closing date of DNV Food Products IPO and Injecto Polymers IPO is , and , respectively.
DNV Food Products IPO P/E ratio is , as compared to Injecto Polymers IPO P/E ratio of .
| DNV Food Products IPO | Injecto Polymers IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)DNV Food Products Ltd.'s revenue increased by 55% and profit after tax (PAT) rose by 128% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Injecto Polymers Ltd.'s revenue increased by 138% and profit after tax (PAT) rose by 82% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 89.53 | 88.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 30.17 | 23.66 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 28.93 | 13.91 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.13 | 2.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 23.74 | 17.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the DNV Food Products IPO Retail Individual Investors (RII) are offered 0 shares while in Injecto Polymers IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in DNV Food Products IPO and 0 shares in Injecto Polymers IPO.
| DNV Food Products IPO | Injecto Polymers IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 2,70,000 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
DNV Food Products IPO subscribed in total, whereas Injecto Polymers IPO subscribed .
